T. Celkan Et Al. , "Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII," PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.24, no.2, pp.117-121, 2007
Celkan, T. Et Al. 2007. Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.24, no.2 , 117-121.
Celkan, T., Alhaj, S., Civilibal, M., & Elicevik, M., (2007). Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII. PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.24, no.2, 117-121.
Celkan, Tiraje Et Al. "Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII," PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.24, no.2, 117-121, 2007
Celkan, Tiraje Et Al. "Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.24, no.2, pp.117-121, 2007
Celkan, T. Et Al. (2007) . "Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII." PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.24, no.2, pp.117-121.
@article{article, author={Tiraje Celkan Et Al. }, title={Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor VII}, journal={PEDIATRIC HEMATOLOGY AND ONCOLOGY}, year=2007, pages={117-121} }